| CXSL1900135 | 注射用SYB507 | SYB-507 | Lyophilized | Biological Products(2) | New Drug Application | 2019-12-06 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | In Review | 2019-12-05 | view |
| CYSB2000241 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-10-29 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | Certificate Issued | 2021-01-15 | view |
| CXSS2000002 | 人纤维蛋白原 | Human fibrinogen | Lyophilized | Biological Products(15) | New Drug Application | 2020-02-14 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | Certificate Issued | 2021-11-10 | view |
| CYSB2000245 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-10-29 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | Certificate Issued | 2021-01-15 | view |
| CYSB2000240 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-10-29 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | Certificate Issued | 2021-01-15 | view |
| CXSS2000001 | 人凝血因子Ⅷ | Recombinant Coagulation Factor Ⅷ | Lyophilized | Biological Products(15) | New Drug Application | 2020-01-18 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | In Review | 2020-01-17 | view |
| CYSB2000244 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-10-29 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | Certificate Issued | 2021-01-15 | view |
| CYSB2000239 | 静注乙型肝炎人免疫球蛋白（pH4） | human hepatitis B immunoglobulin(pH4) | Injection | Biological Products | Supplementary Application | 2020-10-29 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | Certificate Issued | 2021-01-15 | view |
| CXSS1900050 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(7) | New Drug Application | 2019-12-26 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | In Review | 2019-12-25 | view |
| CYSB2000243 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-10-29 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | Certificate Issued | 2021-01-15 | view |
| CYSB2000263 | 人免疫球蛋白 | human immunoglobulin | Injection | Biological Products | Supplementary Application | 2020-11-07 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | Certificate Issued | 2021-02-01 | view |
| CXSS1900051 | 人凝血酶原复合物 | human prothrombin complex | Lyophilized | Biological Products(15) | New Drug Application | 2019-12-26 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | In Review | 2019-12-25 | view |
| CYSB2000242 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-10-29 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | Certificate Issued | 2021-01-15 | view |
| CYSB2000162 | 静注人免疫球蛋白（pH4） | human immunoglobulin(PH4) | Injection | Biological Products | Supplementary Application | 2020-07-04 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | Certificate Issued | 2021-07-16 | view |
